Obstetricians Predict Problems If Reproductive Drugs Go Behind The Counter
This article was originally published in The Tan Sheet
Executive Summary
Pharmacists may realize they "have grabbed the tiger by the tail" if behind-the-counter status is given to what are now prescription reproductive medicines, according to an American College of Obstetricians and Gynecologists official